Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 769, pseudogene (RN7SL769P) is a genomic sequence in humans that resembles the functional 7SL RNA gene, a component of the signal recognition particle (SRP)[1][5][7]. RN7SL769P is considered a **pseudogene**: it is a truncated, nonfunctional copy of the 7SL RNA gene that most likely arose through reverse transcription and insertion into the genome, lacking the capability to produce functional RNA, participate in SRP complex formation, or mediate protein targeting[4][5][7]. Unlike the canonical 7SL RNA, which is important for co-translational protein targeting and can be involved in cancer cell proliferation, RN7SL769P does not appear to have a biological function, established disease associations, or significance as a drug target[4][5][7].
None documented
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 769, pseudogene (RN7SL769P).